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Abstract 
Background Evidence describing the association between pulmonary function and carotid 
atherosclerosis has been inconclusive and the role of smoking in this association is unclear. We 
therefore examined this association in the Guangzhou Biobank Cohort Study-CVD Subcohort. 
Methods Common carotid artery (CCA) intima-media thickness (IMT) and carotid plaques were 
measured by B-mode ultrasonography and lung function by spirometry using a turbine flowmeter. 
Chronic obstructive pulmonary disease (COPD) was defined as the ratio of forced expiratory volume 
in 1 second (FEV1) to forced vital capacity (FVC) of less than 0.70. Predicted FEV1 and FVC were 
derived using equations for Chinese. 
Results Of 1625 participants aged 50+ years, 382 (23.5%) had evidence of carotid plaque. The mean 
CCA-IMT was higher in those with COPD than those without (0.82±0.29mm versus 0.76±0.31mm, 
P=0.02). We found no evidence that the association of pulmonary function with CCA-IMT varied by 
smoking status (P values interaction: 0.23-0.83). After adjustment for a wide range of potential 
confounders, the increased risks of thickened CCA-IMT (CCA-IMT ≥1.0mm) in those with COPD 
became marginally nonsignificant (adjusted odds ratio (OR) 1.45, 95% confidence interval (CI) 
0.91-2.29; P=0.12). Compared to those in the highest tertile, participants in the lowest tertile of FEV1 
observed to predicted ratio had increased risk of thickened CCA-IMT (adjusted OR 2.18, 95% CI 
1.42-3.34) and carotid plaque (adjusted OR 1.50, 95% CI 1.08-2.09), while participants in the lowest 
tertile of FVC observed to predicted ratio had increased risk of thickened CCA-IMT (adjusted OR 
2.29, 95% CI 1.46-3.58), but the adjusted OR for carotid plaque was marginally nonsignificant 
(adjusted OR 1.29, 95% CI 0.93-1.80; P =0.13).  
Conclusion: Independent of smoking status, poor pulmonary function was dose-dependently 
associated with carotid atherosclerosis in older Chinese. (281 words) 
Keywords 
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Introduction 
Cardiovascular disease (CVD) is one of the leading causes of death globally, and the associated 
morbidity and mortality is rapidly increasing in China.1 Poor pulmonary function has been linked to 
a higher risk of CVD in previous studies.2-4 This may result from an induced systemic inflammatory 
response, leading to endothelial dysfunction or vascular alterations that are characterized by increase 
in vascular permeability and formation of plaques.2 Common carotid artery (CCA) intima-medial 
thickness (IMT) and the presence of carotid plaques are well accepted surrogate markers for 
atherosclerosis. However, the results describing the association of poor pulmonary function with 
thicker carotid IMT are inconsistent.5-11  
 
As smoking causes both chronic obstructive pulmonary disease (COPD)12 and atherosclerosis,13, 14 
some studies showed that the association between pulmonary function and atherosclerosis varied by 
smoking status.5, 15-17 For example, the Atherosclerosis Risk in Communities (ARIC) Study showed 
that poor pulmonary function was significantly associated with atherosclerosis in smokers but not in 
never smokers.5 Other studies, such as the Etude sur le Vieillissement Artériel study6 and the 
Multi-Ethnic Study of Atherosclerosis Study (MESA),18 reported a significant association of poor 
pulmonary function with atherosclerosis in both smokers and never smokers. Whether the 
association between pulmonary function and atherosclerosis varies by smoking status is unclear.  
 
Few studies have assessed the association of pulmonary function with carotid atherosclerosis in 
Chinese populations. We found only one study from China showing a significant association of poor 
pulmonary function and higher IMT.19 In that study, low forced expiratory volume in 1 second (FEV1) 
but not low forced vital capacity (FVC) was associated with a thicker carotid IMT in smokers.19 
However, whether the association of pulmonary function with carotid plaque varies by smoking 
status was not assessed.19 Hence, we examined the association of poor pulmonary function with 
carotid atherosclerosis in an older Chinese sample from the Guangzhou Biobank Cohort Study-CVD 
Subcohort. 
 
Methods 
Study participants  
Details of the Guangzhou Biobank Cohort Study (GBCS) have been described elsewhere.20 Briefly, it 
is a three-way collaboration among the Guangzhou Number 12 Hospital, the Universities of Hong 
Kong and Birmingham. A total of 30518 older Chinese in Guangzhou were recruited at baseline from 
2003 to 2008. The Cardiovascular Disease Subcohort (GBCS-CVD) included 1996 participants from 
phase 3 of GBCS.21 A standardized computer-based questionnaire was used by trained interviewers 
to collect information on the demographic characteristics, family and personal disease history and 
lifestyle, including smoking, alcohol drinking and physical activity according to the International 
Physical Activity Questionnaire (IPAQ). Physical examination included height, weight, waist 
circumference and blood pressure. Blood glucose, lipids and high-sensitivity C-reactive protein 
(hs-CRP) were assayed after an overnight (>8 hours) fast. Hypertension was defined as systolic 
blood pressure ≥140mmHg, diastolic blood pressure ≥90mmHg, or self-reported use of 
antihypertensive medication. Diabetes was defined as fasting glucose >7.0 mmol/L or 2 hours oral 
glucose tolerance test (OGTT) >11.1 mmol/L or previous diagnosis of diabetes or use of antidiabetic 
medication. Ethical approval was obtained from the Guangzhou Medical Ethics Committee of the 
Chinese Medical Association, Guangzhou, China. All participants gave written, informed consent 
before participating in the study. 
 
Exposures 
Spirometry was done by a turbine flowmeter (Cosmed microQuark, Rome, Italy), and we had 
described the details elsewhere.22 The pulmonary function test was conducted in a standing position 
following standard procedures, with at least three maneuvers and the best measure of FEV1 and FVC 
were recorded. Predicted values for FEV1 and FVC were derived using the equations of Ip and 
colleagues for Chinese.23 COPD was defined by FEV1/FVC <0.70 according to the Global Initiative 
for Chronic Obstructive Lung Disease (GOLD) guidelines without the use of a bronchodilator. The 
cutoff points of the tertiles of the FEV1 observed to predicted ratio were as follows: tertile 1, <91.2%; 
tertile 2, 91.2%–104.4%; and tertile 3, >104.4%. The cutoff points of the tertiles of FVC observed to 
predicted ratio were as follows: tertile 1, <90.5%; tertile 2, 90.5%–102.8%; and tertile 3, >102.8%.  
 
Study outcomes 
CCA-IMT and carotid artery plaque, measured by B-mode ultrasonography, are non-invasive 
quantitative measures of the presence and severity of carotid atherosclerosis.24 We had reported the 
details of these measures elsewhere.21, 25, 26 Briefly, the participants had carotid B-mode 
ultrasonographic examination using ALT HDI 3000 mainframe with a high-resolution, linear array 
scanner (medium frequency 7.5 MHz), performed by a registered specialist physician. All scans were 
performed following a predetermined, standardized scanning protocol for the right and left carotid 
arteries using images of the far wall of the distal 10 mm of the common carotid arteries. Three 
scanning angles, with the image focused on the posterior wall, were recorded from the angle showing 
the greatest distance between the lumen-intima interface and the media-adventitia interface. All scans 
were analyzed by the same physician, blinded to subjects’ information. When thicker CCA-IMT or 
carotid plaque were observed, at least two physicians, including one chief physician, discussed and 
made the final decision by consensus.  
 
The thickest measures of the left and right bilateral CCA-IMT were obtained, and the means used in 
the analyses. The presence of thickened CCA-IMT was diagnosed when one or both of the left or 
right CCA-IMT was ≥1.0mm.27 A plaque was defined as a distinct area protruding ≥1.2mm into the 
vascular lumen of the carotid artery.28 Participants with one or more plaques in the CCA, internal 
carotid arteries or bifurcations of carotid arteries, on the right or left side were categorized as having 
carotid plaque. The pulmonary function tests and the measurements of vascular morphological 
parameters were conducted during the same visit. 
 
Statistical analysis 
Continuous variables were analyzed using independent sample t-test and categorical variables using 
χ2 test. Multivariable logistic regression was used to calculate odds ratio (OR) of presence of 
thickened CCA-IMT and carotid plaque for (a) COPD status, (b) FEV1 observed to predicted ratio 
tertiles, and (c) FVC observed to predicted ratio tertiles with and without adjustment for multiple 
potential confounders. Model 1 adjusted for the following potential confounders: age (years), 
education (primary or below, middle school, college or above), occupation (manual, non-manual and 
others), smoking (never smokers, ex-smokers, current smokers with 0-29 pack-years and current 
smokers with 30+ pack-years), alcohol drinking (never drinkers, ex-drinkers and current drinkers), 
occupational dust exposure, self-rated health and IPAQ physical activity (physically active, moderate 
and inactive) and model 2 additionally adjusted for body mass index (BMI) (kg/m2), hs-CRP, 
low-density lipoprotein (LDL)-cholesterol (mmol/l), triglycerides (mmol/l), systolic blood pressure 
(mmHg) and diabetes. 
 
We tested for interaction between pulmonary function and sex/smoking using likelihood ratio test to 
test for the fitness of models with or without the interaction terms. Models with a lower Akaike 
information criterion (AIC) value indicate better fitness. We also performed analysis examining the 
association of pulmonary function with atherosclerosis by sex or smoking status as sensitivity 
analysis. All tests of significance were 2-tailed, with p <0.05 as statistically significant. All analyses 
were performed using SPSS version 19.0 (SPSS Inc., Chicago, Illinois, USA).  
 Results  
Of 1996 participants in the GBCS-CVD Subcohort, 1625 (81%) participants with all the information 
of interest were included in the current analyses. The mean age was 59.4 years (standard deviation, 
6.8). Half of the participants were women (49.5%) and 9.7% had COPD. Table 1 shows that 
compared to those without COPD, those with COPD were older, had lower socioeconomic position 
(lower education and more manual occupation), were less physically active, and more likely to be 
men and smokers, and tended to have poor self-rated health and hypertension. They also had higher 
hs-CRP, systolic blood pressure, CCA-IMT levels and a higher prevalence of carotid plaque, but had 
lower BMI and lipids (all P <0.05 except for HDL-cholesterol). 
 
We found no evidence that the association of pulmonary function with carotid atherosclerosis 
(presence of carotid plaque or thickened CCA-IMT) varied by sex or smoking status (P values for 
sex interaction: 0.17-0.57, and for smoking interaction: 0.23-0.83). Hence, all analyses were 
conducted in men and women together with adjustment for sex and smoking. Table 2 model 2 shows 
that, compared to those without COPD, the increased risk of thickened CCA-IMT in participants 
who had COPD became marginally non-significant (adjusted odds ratio (OR) 1.45, 95% CI 
0.91-2.29; P =0.12) after adjustment for age, sex, BMI, occupation, education, occupational dust 
exposure, self-rated health, physical activity, smoking, alcohol drinking, hs-CRP, LDL-cholesterol, 
triglycerides, systolic blood pressure and diabetes. However, the association of COPD with the 
presence of carotid plaque became non-significant after adjustment for the multiple potential 
confounders (adjusted OR 1.06, 95% CI 0.71-1.59). 
 
Compared with participants in the highest tertile, those in the lowest tertile of FEV1 observed to 
predicted ratio had increased risk of thickened CCA-IMT (adjusted OR 2.18, 95% CI 1.42-3.34) and 
the presence of carotid plaque (adjusted OR 1.50, 95% CI 1.08-2.09) (Table 3 model 2), while those 
in the lowest tertile of FVC observed to predicted ratio had increased risk of thickened CCA-IMT 
(adjusted OR 2.29, 95% CI 1.46-3.58) (Table 4 model 2). The association of lower FVC with the 
presence of carotid plaque became marginally non-significant after adjustment for multiple potential 
confounders (adjusted OR 1.29, 95% CI 0.93-1.80; P =0.12) (Table 4). Generally, the association of 
poorer pulmonary function with carotid atherosclerosis showed dose-response relationships (P values 
for trend ranged from <0.001 to 0.005). 
 
Stratified analysis by smoking status (Appendix Tables 1 and 2) and sex (Appendix Tables 3 and 4) 
showed similar results. Compared to participants in the highest tertile of FEV1 observed to predicted 
ratio, the adjusted OR of thickened CCA-IMT for those in the lowest tertile of FEV1 observed to 
predicted ratio was 3.00 (95% CI 1.58-5.71) in ever smokers and 1.47 (95% CI 0.83-2.59; P =0.18) 
in never smokers (Appendix Table 1), and 2.16 (95% CI 1.32-3.55) in men and 3.34 (95% CI 
1.19-9.39) in women (Appendix Table 3). The adjusted ORs of thickened CCA-IMT by FVC 
observed to predicted ratio were similar in ever smokers (OR 1.77, 95% CI 0.95-3.29, P =0.07) and 
never smokers (OR 1.98, 95% CI 1.07-3.65, P =0.03), but seemed to be higher in women than men 
(3.41, 95% CI 1.22-9.55, and 1.52, 95% CI 0.93-2.49, P =0.10, respectively) (Appendix Tables 2 and 
4). 
 
Discussion 
Our study showed that poorer pulmonary function, indicated by COPD, lower FEV1 and FVC, was 
dose-dependently associated with thickened CCA-IMT and carotid plaque. Furthermore, we found 
no evidence that the associations varied by sex or smoking status with significant associations being 
found in both never and ever smokers as well as in both sexes. Poor pulmonary function was 
associated with a higher risk of carotid atherosclerosis in most,10, 29-31 but not all, of the earlier 
cross-sectional5-10, 15-19, 29-31 or prospective6, 7 studies.  
 
Most of earlier studies showed lower FEV1 was associated with thicker IMT3, 5, 8, 15, 18and the 
presence of subclinical atherosclerosis,3, 7, 10, 15 However, a small study by Pike et al. of 61 subjects 
without airflow limitation found that FEV1 was not associated with IMT .17 Similarly, most of the 
previous studies reported significant association of lower FVC observed to predicted ratio and 
FEV1/FVC ratio with carotid IMT.18, 19 Whether the association varied by smoking status was unclear. 
One study of 3642 participants showed that, when stratified by smoking status, no association of 
FVC with CCA or ICA-IMT in smokers was found.18 The major limitation of this study was the lack 
of concurrent measures with the lung function being assessed about 4 years after the measures of 
carotid atherosclerosis.  
 
Few studies have assessed the association between pulmonary function and carotid IMT in Chinese 
populations. We found only one study by Ma et al. which showed that lower FVC observed to 
predicted ratio and FEV1 observed to predicted ratio were significantly associated with thicker IMT 
in all participants and in never smokers after adjustment for potential confounders.19 Only FEV1 
observed to predicted ratio, but not FVC observed to predicted ratio, was associated with carotid 
IMT in smokers, probably because of the small number of smokers (n=74 in the 4th quartile). 
Moreover, due to the limited sample size, the authors did not assess the interaction of smoking 
categories with lung function. Our findings extended the observations from Ma’s study and further 
showed dose-response relationships of poorer pulmonary function with thickened CCA-IMT in both 
never smokers and ever smokers.  
 
In our study, we found no evidence that the association between pulmonary function and carotid 
atherosclerosis varied by sex. Few studies examined sex interaction, and for those that did, the results 
were mixed.5, 6 A study of 656 older French people found significant associations between lung 
function and atherosclerosis in both men and women, and the associations did not vary by sex 
(P=0.91).6 However, another study of 14000 American participants found that the association was 
stronger in women than in men among never smokers (P for sex interaction <0.001).5 Taken together, 
whether the association of lung function and atherosclerosis varies by sex or depends on some 
sex-specific factors remains unclear.  
 
Lung inflammation due to COPD may lead to a systemic inflammatory response with increase in 
circulating leukocytes, platelets, cytokines, and acute-phase proteins.2 These mediators activate the 
vascular endothelium, causing endothelial dysfunction which is characterized by reduced 
vasodilatation with decreased nitric oxide (NO) and increased endothelin (ET) expression; increased 
vascular permeability and the uptake of oxidized low-density lipoproteins (LDL) promoting the 
development of atherosclerotic plaque.2 A ventilation/perfusion mismatch associated with impaired 
pulmonary function and a systemic inflammatory response have been proposed as the mechanisms 
for this association.2 A lower ventilation/perfusion ratio due to impaired lung function may result in 
chronic arterial wall hypoxia. 32 Arterial medial hypoxia might stimulate release of growth factors 
and cytokines which may initiate a series of changes including macrophage migration and activation, 
increased endothelial permeability, and platelet adherence and degranulation, intimal and adventitial 
proliferation that decreases trans-intimal oxygen delivery. 32 Ultimately, a pathophysiological 
positive feedback loop is completed and the atherosclerosis is resulted.32 Moreover, Sabater-Lleal et 
al. described genetic factors (i.e., rs9978142 and rs3995090 located in the HTR4 gene) that were 
implicated in determining human lung function also influenced carotid IMT supporting a molecular 
basis of the co-localization of these co-morbidities.33 Independently from the common vascular risk 
factors, common genetic pathways existing between impaired lung function and atherosclerosis 
could be the fundamental mechanism for this association.33 Ventilation/perfusion mismatch and 
systemic inflammation might exacerbate this association.2 
 
There were several limitations in our study. Common to all such cohorts, as our participants being 
older and therefore survivors, healthy volunteer bias could not be fully ruled out. The number of 
participants with airflow limitation and smokers was relatively small and we did not perform 
post-bronchodilator spirometry. However, all earlier population-based studies on pulmonary function 
and cardiovascular risk were similarly based on pre-bronchodilator spirometry measurements.34 We 
also could not ascertain the time sequences between changes in pulmonary function and the vascular 
morphological parameters. Some of the potential confounders could also be mediators, and the 
multivariate adjustment could have led to an underestimation of the true effect, although that would 
have been more of an issue had we not observed such associations. Similarly, our sample size could 
be insufficient to test small interaction effects, but again given the associations in the sex-specific 
analyses and in never and ever smokers were similar, this is unlikely to be a major issue. Finally, 
residual confounding could not be fully ruled out. For instance, non-occupational environmental dust 
exposure might adversely contribute to both vascular and pulmonary function.35 Renal function 
(estimated glomerular filtration rate) and other determinants of IMT (e.g. serum uric acid) might also 
confound the observed association.36 Further studies need to consider these factors to clarify the most 
important factors directly involved in the disease aetiology. The causal association between 
pulmonary function and carotid atherosclerosis could not be confirmed in this cross-sectional 
analysis.  
 
In conclusion, we found that poorer pulmonary function was associated with higher risk of carotid 
atherosclerosis after adjusting for multiple potential confounders including smoking, and the 
association did not vary by sex or smoking status. Given the relatively small sample and 
cross-sectional nature of our study, further large prospective studies are warranted. If our results were 
confirmed, subclinical atherosclerosis screening in people with poor pulmonary function may 
identify those at high risk of atherosclerosis and measures to prevent further progress and 
complications would be needed.   
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Table 1.Characteristics of the study sample by pulmonary function status  
 Normal 
FEV1/FVC ≥0.70 
COPD 
FEV1/FVC <0.70 
P value 
Number  1467 158  
Men, n (%) 697 (47.5) 124 (78.5) <0.001 
Age (y) 58.7±6.4 65.0±7.7 <0.001 
Occupation, n (%)    <0.001 
  Manual 338 (23.0) 60(38.0)  
  Non-manual  741 (50.5) 68 (43.0)  
  Others 388 (26.4) 30 (19.0)  
Education, n (%)   <0.001 
  ≤Primary  376 (25.6) 69 (43.7)  
  Middle school 900 (61.3) 70 (44.3)  
  ≥College 191 (13.0) 19 (12.0)  
Smoking, n (%)   <0.001 
  Never 1062 (72.4) 60 (38.0)  
  Former 182 (12.4) 41 (25.9)  
  Current(0-29 pack-years) 116 (7.9) 20(12.7)  
Current(≥30 pack-years) 107 (7.3) 37 (23.4)  
Drinking, n (%)   0.26 
  Never 549 (37.4) 57 (36.1)  
  Former 40 (2.7) 8 (5.1)  
  Current 878 (59.9) 93 (58.9)  
Occupational dust exposure, n (%) 51 (3.5) 8 (5.1) 0.31 
IPAQ Physical activity, n (%)   0.03 
High 880 (60.0) 83 (52.5)  
Moderate 429 (29.2) 62 (39.2)  
Low 158 (10.8) 13 (8.2)  
Self-rated poor health status, n (%) 233(15.9) 41(25.9) 0.001 
Body mass index, kg/m2 23.9±3.0 22.8±2.9 <0.001 
Waist circumference, cm  78.5±8.9 78.8±8.3 0.72 
Hypertension, n (%) 487 (33.2) 68 (43.0) 0.01 
Diabetes, n (%)  137 (9.3) 18 (11.4) 0.40 
Systolic blood pressure, mmHg  127±20 132±21 0.005 
Diastolic blood pressure, mmHg  74±11 75±10 0.63 
Total cholesterol, mmol/l  5.87±1.09 5.69±1.09     0.04 
HDL-cholesterol, mmol/l  1.57±0.40 1.60±0.37 0.53  
LDL-cholesterol, mmol/l  3.39±0.68 3.26±0.65 0.03 
Triglycerides, mmol/l  1.87±1.48 1.60±0.91 0.001  
Fasting plasma glucose, mmol/l 5.59±1.41 5.54±1.10 0.70 
hs-CRP, mg/l 2.44±2.83 3.13±3.59 0.02 
Mean CCA-IMT, mm 0.76±0.31 0.82±0.29 0.02 
Thickened CCA-IMT, n (%) 158 (10.8) 41 (25.9) <0.001 
FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; COPD, chronic obstructive 
pulmonary disease; IPAQ, International Physical Activity Questionnaire; hs-CRP, high-sensitivity 
C-reactive protein; CCA-IMT, common carotid artery-intima-media;  
Thickened CCA-IMT: CCA-IMT ≥1.0mm  
Carotid plaque, n (%) 316 (21.5) 66 (41.8) <0.001 
Number of carotid plaque, n (%)    
0 1151 (78.5) 92 (58.2) <0.001 
1 208 (14.2) 26 (16.5)  
2+ 108 (7.4) 40 (25.3)  
Table 2. Odds ratios (ORs) for the presence of carotid atherosclerosis by COPD status 
 COPD P value No (n=1467) Yes (n=158) 
Presence of thickened CCA-IMT, n (%) 158 (10.8) 41 (25.9)  
Crude OR (95%CI) 1.00 2.90 (1.96-4.30)** <0.001 
Model 1, OR (95%CI)  1.00 1.32 (0.84-2.06) 0.23 
Model 2, OR (95%CI) 1.00 1.45 (0.91-2.29) 0.12 
    
Presence of carotid plaque, n (%) 316 (21.5) 66 (41.8)  
Crude OR (95%CI) 1.00 2.61 (1.86-3.67)** <0.001 
Model 1, OR (95%CI) 1.00 1.08 (0.72-1.60) 0.72 
Model 2, OR (95%CI) 1.00 1.06(0.71-1.59) 0.77 
COPD, chronic obstructive pulmonary disease; CCA-IMT, common carotid artery intima-median 
thickness;  
Model 1: Adjusted for sex, age, education, occupation, smoking, drinking, occupational dust 
exposure, self-rated health and physical activity. 
Model 2: Additionally adjusted for body mass index, high-sensitivity C-reactive protein, 
LDL-cholesterol, triglycerides, systolic blood pressure and diabetes. 
Thickened CCA-IMT: CCA-IMT ≥1.0mm 
*P<0.05; **P<0.01  
Table 3. Odds ratios (ORs) for the presence of carotid atherosclerotic by tertiles of FEV1 observed to 
predicted ratio  
 FEV1 observed to predicted ratio (%) P for 
trend  Tertile 1 Tertile 2 Tertile 3 
Range, % <91.2 91.2-104.4 >104.4  
Number of participants  541 543 541  
Presence of thickened CCA-IMT, n (%) 103 (19.0) 58 (10.7) 
 
38 (7.0)  
Crude OR (95%CI) 3.11 (2.10-4.61)** 1.58 (1.03-2.43)* 1.00 <0.001 
Model 1, OR (95%CI) 2.27 (1.49-3.45)** 1.55 (0.99-2.42) 1.00 0.001 
Model 2, OR (95%CI) 2.18 (1.42-3.34)** 1.49 (0.94-2.34) 1.00 0.001 
     
Presence of carotid plaque, n (%) 159 (29.4) 134 (24.7) 89 (16.5)  
Crude OR (95%CI) 2.11 (1.58-2.83)** 1.66 (1.23-2.25)** 1.00 <0.001 
Model 1, OR (95%CI) 1.51 (1.09-2.10)* 1.76 (1.27-2.44)** 1.00 0.003 
Model 2, OR (95%CI) 1.50 (1.08-2.09)* 1.71 (1.23-2.39)** 1.00 0.005 
FEV1, forced expiratory volume in 1 second; CCA-IMT, common carotid artery intima-median 
thickness; 
Model 1: Adjusted for sex, age, education, occupation, smoking, drinking, occupational dust 
exposure, self-rated health and physical activity. 
Model 2: Additionally adjusted for body mass index, high-sensitivity C-reactive protein, 
LDL-cholesterol, triglycerides, systolic blood pressure and diabetes. 
Thickened CCA-IMT: CCA-IMT ≥1.0mm 
*P<0.05; **P<0.01
Table 4 Odds ratios (ORs) for the presence of carotid atherosclerotic by tertiles of FVC observed to 
predicted ratio  
 FVC observed to predicted ratio(%) P for 
trend  Tertile 1 Tertile 2 Tertile 3 
Range, % <90.5 90.5-102.8 >102.8  
Number of participants  541 542 542  
Presence of thickened CCA-IMT, n (%) 99 (18.3) 67 (12.4) 33 (6.1)  
Crude OR (95%CI) 3.46 (2.28-5.23)** 2.18 (1.41-3.36)** 1.00 <0.001 
Model 1, OR (95%CI) 2.48 (1.60-3.85)** 2.27 (1.44-3.57)** 1.00 <0.001 
Model 2, OR (95%CI) 2.29 (1.46-3.58)** 2.20 (1.39-3.49)** 1.00 0.001 
     
Presence of carotid plaque, n(%) 161 (29.8) 125 (23.1) 96(17.7)  
Crude OR (95%CI) 1.97 (1.48-2.62)** 1.39 (1.03-1.88)* 1.00 <0.001 
Model 1, OR (95%CI) 1.33 (0.96-1.83) 1.45 (1.05-2.01)* 1.00 0.07 
Model 2, OR (95%CI) 1.29 (0.93-1.80) 1.44 (1.03-2.00)* 1.00 0.09 
FVC, forced vital capacity; CCA-IMT, common carotid artery intima-median thickness; 
Model 1: Adjusted for sex, age, education, occupation, smoking, drinking, occupational dust 
exposure, self-rated health and physical activity. 
Model 2: Additionally adjusted for body mass index, high-sensitivity C-reactive protein, 
LDL-cholesterol, triglycerides, systolic blood pressure and diabetes. 
Thickened CCA-IMT: CCA-IMT ≥1.0mm 
*P<0.05; **P<0.01  
Appendix Table 1. Odds ratios (ORs) for the presence of carotid atherosclerotic by tertiles of FEV1 
observed to predicted ratio and by smoking status 
 FEV1 observed to predicted ratio (%) P for trend 
 Tertile 1 Tertile 2 Tertile 3 
Ever smokers 
Range, % <85.4 85.4-99.6 >99.6  
Number  167 168 168  
Presence of thickened CCA-IMT, n (%) 51 (30.5) 35 (20.8 ) 18 (10.7)  
Crude OR (95%CI) 3.66 (2.03-6.61)** 2.19 (1.19-4.05)* 1.00 <0.001 
Model 1, OR (95%CI) 3.08 (1.64-5.80)** 2.27 (1.18-4.34)* 1.00 0.002 
Model 2, OR (95%CI) 3.00 (1.58-5.71)** 2.04 (1.05-3.95)* 1.00 0.004 
     
Presence of carotid plaque n (%) 72 (43.1) 68 (40.5) 43 (25.6)  
Crude OR (95%CI) 2.20 (1.39-3.50)** 1.98 (1.24-3.14)** 1.00 0.002 
Model 1, OR (95%CI) 1.67 (1.00-2.78) 2.18 (1.32-3.63)** 1.00 0.01 
Model 2, OR (95%CI) 1.76 (1.04-2.98)*  2.39 (1.42-4.03)**  1.00 0.004 
     
Never smokers 
Range, % <93.7 93.7-105.9 >105.9  
Number  374 374 374  
Presence of thickened CCA-IMT, n (%) 41 (11.0) 30 (8.0) 24 (6.4)  
Crude OR (95%CI) 1.80 (1.06-3.04)* 1.27 (0.73-2.22) 1.00 0.08 
Model 1, OR (95%CI) 1.53 (0.88-2.64)* 1.26 (0.70-2.25) 1.00 0.31 
Model 2, OR (95%CI) 1.47 (0.83-2.59) 1.25 (0.69-2.27) 1.00 0.41 
      
Presence of carotid plaque, n (%)  78 (20.9) 65 (17.4) 56 (15.0)  
Crude OR (95%CI) 1.50 (1.03-2.18)* 1.20 (0.81-1.77) 1.00 0.11 
Model 1, OR (95%CI) 1.32 (0.88-2.00) 1.34 (0.88-2.05) 1.00 0.31 
Model 2, OR (95%CI) 1.26 (0.82-1.92) 1.29 (0.83-1.98) 1.00 0.46 
FEV1, forced expiratory volume in 1 second; CCA-IMT; common carotid artery intima-median 
thickness;  
Model 1: Adjusted for sex, age, education, occupation, drinking, occupational dust exposure, 
self-rated health and physical activity. 
Model 2: Additionally adjusted for body mass index, high-sensitivity C-reactive protein, 
LDL-cholesterol, triglycerides, systolic blood pressure and diabetes. 
Thickened CCA-IMT: CCA-IMT ≥1.0mm 
P for smoking interaction (ever smokers vs. never smokers): (1) thickened CCA-IMT: 0.23; (2) 
carotid plaque: 0.53 
*P<0.05;**P<0.01  
Appendix Table 2. Odds ratios (ORs) for the presence of carotid atherosclerotic by tertiles of FVC 
observed to predicted ratio and smoking status 
 FVC observed to predicted ratio (%) P for 
trend  Tertile 1 Tertile 2 Tertile 3 
Ever smokers 
Range, % <86.1 86.1-99.9 >99.9  
Number  167 168 168  
Presence of thickened CCA-IMT, n (%) 46 (27.5) 36 (21.4) 22 (13.1)  
Crude OR (95%CI) 2.52 (1.44-4.43)** 1.81 (1.01-3.23)* 1.00 0.006 
Model 1, OR (95%CI) 1.94 (1.06-3.57)* 1.89 (1.02-3.49)* 1.00 0.07 
Model 2, OR (95%CI) 1.77 (0.95-3.29) 1.69 (0.90-3.16) 1.00 0.15 
     
Presence of carotid plaque, n (%) 72 (43.1) 64 (38.1) 47 (28.0)  
Crude OR (95%CI) 1.95 (1.24-3.08) ** 1.58 (1.001-2.51)* 1.00 0.01 
Model 1, OR (95%CI) 1.42 (0.86-2.36)  1.79(1.09-2.95)* 1.00 0.07 
Model 2, OR (95%CI) 1.51 (0.90-2.54)  1.88 (1.12-3.13)* 1.00 0.05 
     
Never smokers 
Range, % <92.6 92.6-103.7 >103.7  
Number  374 374 374  
Presence of thickened CCA-IMT, n (%) 45 (12.0) 32 (8.6) 18 (4.8)  
Crude OR (95%CI) 2.71 (1.54-4.77)** 1.85 (1.02-3.36)* 1.00 0.003 
Model 1, OR (95%CI) 2.16 (1.19-3.90)* 1.93 (1.04-3.58)* 1.00 0.03 
Model 2, OR (95%CI) 1.98 (1.07-3.65)* 1.95 (1.04-3.68)* 1.00 0.07 
     
Presence of carotid plaque, n (%) 81 (21.7) 60 (16.0) 58 (15.5)  
Crude OR (95%CI) 1.51 (1.04-2.19)* 1.04 (0.70-1.54) 1.00 0.05 
Model 1, OR (95%CI) 1.16 (0.77-1.75) 1.08 (0.71-1.65) 1.00 0.78 
Model 2, OR (95%CI) 1.04 (0.68-1.60) 1.04 (0.67-1.60) 1.00 0.98 
FVC, forced vital capacity; CCA-IMT, common carotid artery intima-median thickness;  
Model 1: Adjusted for sex, age, education, occupation, drinking, occupational dust exposure, 
self-rated health and physical activity. 
Model 2: Additionally adjusted for body mass index, high-sensitivity C-reactive protein, 
LDL-cholesterol, triglycerides, systolic blood pressure and diabetes. 
Thickened CCA-IMT: CCA-IMT ≥1.0mm  
P for smoking interaction (ever smokers vs. never smokers): (1) thickened CCA-IMT: 0.83; (2) 
carotid plaque: 0.57 
*P<0.05; **P<0.01  
Appendix Table 3. Odds ratios (ORs) for the presence of carotid atherosclerosis by tertiles of FEV1 
observed to predicted ratio and by sex 
 FEV1 observed to predicted ratio (%)  P for 
trend  Tertile 1 Tertile 2 Tertile 3 
Men     
Range, % <88.2 88.2-102.3 >102.3  
Number 274 273 274  
Presence of thickened CCA-IMT, n (%) 71 (25.9) 48 (17.6) 32 (11.7)  
Crude OR (95%CI) 2.65 (1.68-4.18)** 1.61 (1.00-2.61) 1.00 <0.001 
Model 1, OR (95%CI) 2.18 (1.34-3.53)** 1.53 (0.93-2.52) 1.00 0.007 
Model 2, OR (95%CI) 2.16 (1.32-3.55)** 1.50 (0.90-2.51) 1.00 0.009 
     
Presence of carotid plaque, n (%) 103 (37.6) 109 (39.9) 68 (24.8)  
Crude OR (95%CI) 1.83 (1.26-2.64)** 2.01 (1.40-2.90)**  1.00 <0.001 
Model 1, OR (95%CI) 1.41 (0.94-2.10) 2.03 (1.37-3.01)** 1.00 0.002 
Model 2, OR (95%CI) 1.41 (0.94-2.12) 2.04 (1.37-3.05)** 1.00 0.002 
     
Women     
Range, % <94.0 94.0-105.7 >105.7  
Number 268 268 268  
Presence of thickened CCA-IMT, n (%) 24 (9.0) 19 (7.1 ) 5 (1.9)  
Crude OR (95%CI) 5.17 (1.94-13.77)** 4.01 (1.48-10.91)** 1.00 0.004 
Model 1, OR (95%CI) 3.96 (1.43-10.94)** 3.81 (1.36-10.70)* 1.00 0.02 
Model 2, OR (95%CI) 3.34 (1.19-9.39)* 3.39 (1.20-9.62)* 1.00 0.05 
     
Presence of carotid plaque, n (%) 48 (17.9) 29 (10.8) 25 (9.3)  
Crude OR (95%CI) 2.12 (1.27-3.56)** 1.18 (0.67-2.07)  1.00 0.007 
Model 1, OR (95%CI) 1.90 (1.08-3.32)* 1.23 (0.68-2.25) 1.00 0.06 
Model 2, OR (95%CI) 1.80 (1.01-3.22)* 1.14 (0.61-2.10) 1.00 0.09 
FEV1, forced expiratory volume in 1 second; CCA-IMT, common carotid artery intima-median 
thickness; 
Model 1: Adjusted for age, education, occupation, smoking, drinking, occupational dust exposure, 
self-rated health and physical activity. 
Model 2: Additionally adjusted for body mass index, high-sensitivity C-reactive protein, 
LDL-cholesterol, triglycerides, systolic blood pressure and diabetes. 
Thickened CCA-IMT: CCA-IMT ≥1.0mm 
P for sex interaction: (1) thickened CCA-IMT: 0.17; (2) carotid plaque: 0.34    
*P<0.05; **P<0.01  
Appendix Table 4. Odds ratios (ORs) for the presence of carotid atherosclerosis by tertiles of FVC 
observed to predicted ratio and by sex 
 FVC observed to predicted ratio (%) P for 
trend  Tertile 1 Tertile 2 Tertile 3 
Men     
Range, % <88.1 88.1-101.1 >101.1  
Number 273 274 274  
Presence of thickened CCA-IMT, n (%) 63 (23.1) 53 (19.3) 35 (12.8)  
Crude OR (95%CI) 2.05 (1.30-3.22)** 1.64 (1.03-2.61)* 1.00 0.008 
Model 1, OR (95%CI) 1.60 (0.99-2.59) 1.75 (1.08-2.84)* 1.00 0.06 
Model 2, OR (95%CI) 1.52 (0.93-2.49) 1.66 (1.02-2.72)* 1.00 0.11 
     
Presence of carotid plaque,n(%) 107 (39.2) 99 (36.1) 74 (27.0)  
Crude OR (95%CI) 1.74 (1.21-2.50)** 1.53 (1.06-2.20)* 1.00 0.008 
Model 1, OR (95%CI) 1.29 (0.87-1.92) 1.65 (1.12-2.44)* 1.00 0.042 
Model 2, OR (95%CI) 1.31 (0.88-1.96) 1.64 (1.11-2.44)* 1.00 0.049 
     
Women     
Range, % <93.1 93.1-103.7 >103.7  
Number 268 268 268  
Presence of thickened CCA-IMT, n (%) 29 (10.8) 14(5.2) 5 (1.9)  
Crude OR (95%CI) 6.38 (2.43-16.75)** 2.90 (1.03-8.17)* 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
1.00 <0.001 
Model 1, OR (95%CI) 4.35 (1.59-11.96)** 2.77(0.96-8.00)  1.00 0.02 
Model 2, OR (95%CI) 3.41 (1.22-9.55)* 2.45 (0.83-7.17)  1.00 0.06 
     
Presence of carotid plaque, n (%) 45 (16.8) 31 (11.6) 26 (9.7)  
Crude OR (95%CI) 1.88 (1.12-3.15)* 1.22 (0.70-2.11)  1.00 0.04 
Model 1, OR (95%CI) 1.30 (0.74-2.31) 1.21 (0.67-2.16) 1.00 0.66 
Model 2, OR (95%CI) 1.09 (0.60-1.98) 1.09 (0.60-1.98) 1.00 0.95 
FVC, forced vital capacity; CCA-IMT, common carotid artery intima-median thickness;  
Model 1: Adjusted for age, education, occupation, smoking, drinking, occupational dust exposure, 
self-rated health and physical activity. 
Model 2: Additionally adjusted for body mass index, high-sensitivity C-reactive protein, 
LDL-cholesterol, triglycerides, systolic blood pressure and diabetes. 
Thickened CCA-IMT: CCA-IMT ≥1.0mm 
P for sex interaction: (1) thickened CCA-IMT: 0.32; (2) carotid plaque: 0.57     
*P<0.05; **P<0.01  
 
 
 
